Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?
Urvi RanaMatt DriedgerPaul SeredaShenyi PanErin DingAlex WongSharon WalmsleyMarina KleinDeborah KellyMona LoutfyRejean ThomasStephen SancheAbigail KrochNima MachoufMarie-Helene Roy-GagnonRobert HoggCurtis L Coopernull nullPublished in: BMC infectious diseases (2019)
The prevalence, demographic and clinical characteristics of the HIV-HBV co-infected population in Canada is described. HIV-HBV co-infected patients have higher mortality, more advanced CD4 T cell depletion, and liver fibrosis that improves in conjunction with ARV therapy. The high prevalence of unknown HBV status demonstrates a need for increased screening among HIV-infected patients in Canada.
Keyphrases